These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23342816)

  • 21. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
    Loree JM; Anand S; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K
    JAMA Oncol; 2019 Oct; 5(10):e191870. PubMed ID: 31415071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
    Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
    Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
    Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
    JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
    Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of race/ethnicity in trials leading to anti-rheumatic drug approval for inflammatory arthritis by the US Food and Drug Administration.
    Xie Y; Liu Y; Qin Y; Chen X; Xie Q
    Int J Rheum Dis; 2023 Dec; 26(12):2489-2497. PubMed ID: 37854006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of women and sex analyses in late-phase clinical trials of new molecular entity drugs and biologics approved by the FDA in 2007-2009.
    Poon R; Khanijow K; Umarjee S; Fadiran E; Yu M; Zhang L; Parekh A
    J Womens Health (Larchmt); 2013 Jul; 22(7):604-16. PubMed ID: 23768021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of women in clinical trials for new drugs approved by the food and drug administration in 2000-2002.
    Yang Y; Carlin AS; Faustino PJ; Motta MI; Hamad ML; He R; Watanuki Y; Pinnow EE; Khan MA
    J Womens Health (Larchmt); 2009 Mar; 18(3):303-10. PubMed ID: 19243271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?
    Dickmann LJ; Schutzman JL
    Oncologist; 2018 Feb; 23(2):243-246. PubMed ID: 29259072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial/Ethnic Disparities in Tobacco Product Use Among Middle and High School Students - United States, 2014-2017.
    Odani S; Armour BS; Agaku IT
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):952-957. PubMed ID: 30161103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.
    Tibau A; Molto C; Ocana A; Templeton AJ; Del Carpio LP; Del Paggio JC; Barnadas A; Booth CM; Amir E
    J Natl Cancer Inst; 2018 May; 110(5):486-492. PubMed ID: 29244173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy.
    Ranganathan S; Haslam A; Tuia J; Prasad V
    J Cancer Policy; 2024 Mar; 39():100462. PubMed ID: 38061492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
    Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
    Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012.
    Sacks LV; Shamsuddin HH; Yasinskaya YI; Bouri K; Lanthier ML; Sherman RE
    JAMA; 2014 Jan 22-29; 311(4):378-84. PubMed ID: 24449316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Science-based Ethnic Bridging in Drug Development; Review of Recent Precedence and Suggested Steps Forward.
    van Hoogdalem EJ; Jones Iii JP; Constant J; Achira M
    Curr Clin Pharmacol; 2019; 14(3):197-207. PubMed ID: 30961506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021.
    Wilson BE; Nadler MB; Desnoyers A; Booth CM; Amir E
    Cancer; 2024 Jan; 130(2):276-286. PubMed ID: 37751315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs.
    Kluetz PG; Keegan P; Demetri GD; Thornton K; Sul J; Kim J; Katzen H; Burke LB; Harvey RD; Alebachew E; Agrawal S; Nair A; Donoghue M; Pierce WF; Shord SS; Gao JJ; Pazdur R
    Clin Cancer Res; 2021 Feb; 27(4):916-921. PubMed ID: 33257426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.